Related Experiment Video
Updated: Jun 11, 2026
08:40
Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy
Published on: August 1, 2013
Photodynamic therapy induces interleukin secretion from dendritic cells
Summary
Photodynamic therapy (PDT) enhances dendritic cell (DC) activation for cancer vaccines by modulating cytokine expression. This approach could improve the efficacy of DC-based cancer immunotherapies.
Area of Science:
- Immunology
- Oncology
- Photochemistry
Background:
- Dendritic cells (DCs) pulsed with tumor antigens are investigated as cancer vaccines.
- Limited therapeutic efficacy necessitates improved DC-based cancer vaccine strategies.
- Photodynamic therapy (PDT) involves photosensitizers and laser activation to target tumors.
Purpose of the Study:
- To investigate the potential of PDT to enhance the tumor microenvironment for DC-based cancer vaccines.
- To determine the effects of PDT on DC cytokine expression.
Main Methods:
- Dendritic cells (DCs) were evaluated in the context of PDT.
- Cytokine expression (IL-1, IL-6, TNF-alpha) in DCs was measured following PDT.
Main Results:
- PDT induced Interleukin-1 (IL-1) and Interleukin-6 (IL-6) expression in DCs.
- PDT reduced Tumor Necrosis Factor-alpha (TNF-alpha) expression in DCs.
- These cytokine modulations are mechanistically linked to PDT's effects on immune responses.
Conclusions:
- PDT can modulate DC cytokine profiles, potentially enhancing antitumor immunity.
- PDT may serve as an adjuvant therapy to improve DC-based cancer vaccines.
- Further research is warranted to explore PDT's role in cancer immunotherapy.
Related Concept Videos
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:24T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...